ReviewEuropean journal of drug metabolism and pharmacokinetics2018

Pharmacology of Pimasertib, A Selective MEK1/2 Inhibitor.

Nuggehally R SrinivasPubMed ↗Publisher ↗

No numbers read from the abstract.